参考文献
1: PLOS Neglected Tropical Diseases Staff. Correction: Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice. PLoS Negl Trop Dis. 2015 Oct 29;9(10):e0004181. doi: 10.1371/journal.pntd.0004181. eCollection 2015 Oct. PubMed PMID: 26512896.
2: Aboagye-Antwi F, Kwansa-Bentum B, Dadzie SK, Ahorlu CK, Appawu MA, Gyapong J, Wilson MD, Boakye DA. Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana. Parasit Vectors. 2015 Oct 26;8(1):562. doi: 10.1186/s13071-015-1105-x. PubMed PMID: 26503363; PubMed Central PMCID: PMC4624376.
3: Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, Schmidt MS, Siba PM, Weil GJ, Kazura JW, Fleckenstein LL, King CL. Efficacy, Safety, and Pharmacokinetics of Co-Administered Diethylcarbamazine, Albendazole, and Ivermectin for the Treatment of Bancroftian Filariasis. Clin Infect Dis. 2015 Oct 20. pii: civ882. [Epub ahead of print] PubMed PMID: 26486704.
4: Escobedo AA, Ballesteros J, González-Fraile E, Almirall P. A meta-analysis of the efficacy of albendazole compared with tinidazole as treatments for Giardia infections in children. Acta Trop. 2015 Oct 14. pii: S0001-706X(15)30121-2. doi: 10.1016/j.actatropica.2015.09.023. [Epub ahead of print] Review. PubMed PMID: 26476393.
5: Romo ML, Wyka K, Carpio A, Leslie D, Andrews H, Bagiella E, Hauser WA, Kelvin EA; Ecuadorian Neurocysticercosis Group. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis. Trans R Soc Trop Med Hyg. 2015 Nov;109(11):738-46. doi: 10.1093/trstmh/trv078. Epub 2015 Oct 3. PubMed PMID: 26433183.
6: Ortonobes Roig S, López García B, Solano Luque MF, Ferrández Quirante O. [Haematological toxicity during treatment with albendazole]. Enferm Infecc Microbiol Clin. 2015 Sep 29. pii: S0213-005X(15)00288-8. doi: 10.1016/j.eimc.2015.07.013. [Epub ahead of print] Spanish. PubMed PMID: 26432766.
7: Pensel PE, Ullio Gamboa G, Fabbri J, Ceballos L, Sanchez Bruni S, Alvarez LI, Allemandi D, Benoit JP, Palma SD, Elissondo MC. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop. 2015 Sep 26;152:185-194. doi: 10.1016/j.actatropica.2015.09.016. [Epub ahead of print] PubMed PMID: 26409727.
8: Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda. Clin Infect Dis. 2015 Sep 25. pii: civ829. [Epub ahead of print] PubMed PMID: 26409064.
9: Belew S, Getachew M, Suleman S, Mohammed T, Deti H, D'Hondt M, Wynendaele E, Mekonnen Z, Vercruysse J, Duchateau L, De Spiegeleer B, Levecke B. Assessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, Ethiopia. PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004057. doi: 10.1371/journal.pntd.0004057. eCollection 2015 Sep. PubMed PMID: 26406600; PubMed Central PMCID: PMC4583991.
10: Abulaihaiti M, Wu XW, Qiao L, Lv HL, Zhang HW, Aduwayi N, Wang YJ, Wang XC, Peng XY. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice. PLoS Negl Trop Dis. 2015 Sep 9;9(9):e0003950. doi: 10.1371/journal.pntd.0003950. eCollection 2015 Sep. PubMed PMID: 26352932; PubMed Central PMCID: PMC4564103.
